Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer

NCT00529113 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped To pursue other indications

Conditions

Pancreatic Neoplasms
Pancreatic Cancer

Interventions

DRUG: Bardoxolone methyl
DRUG: Bardoxolone methyl
DRUG: Bardoxolone methyl
DRUG: Bardoxolone methyl
DRUG: Bardoxolone methyl
DRUG: Bardoxolone methyl
DRUG: Bardoxolone methyl
DRUG: Gemcitabine
DRUG: Placebo
DRUG: Bardoxolone methyl

Sponsor

Biogen